Key result
EP-guided surgery for life-threatening VT yields ~5% recurrence in ischemic cases while AICD provides high survival.
Why the study?
What are the clinical outcomes of electrophysiologically guided surgery, AICD, and heart transplantation in patients with life-threatening ventricular tachycardia?
Population
154 patients with life-threatening ventricular tachycardia (83% ischemic and 17% nonischemic heart disease).
Design
Case_series
Follow-up
Up to 1 year for AICD; 3-20 months for transplantation
Authors
Loading...
May support guided surgery in ischemic VT; hypothesis-generating and should not change practice without prospective data.
Observational (n=154)
What are the clinical outcomes of electrophysiologically guided surgery, AICD, and heart transplantation in patients with life-threatening ventricular tachycardia?
Electrophysiologically guided surgery is highly effective for ischemia-related ventricular tachycardia, while AICD and heart transplantation serve as important palliative, bridging, or definitive alternatives depending on ventricular function and disease progression.
Frank et al. (1988) conducted an observational in Life-threatening ventricular tachycardia (n=154). Electrophysiologically guided surgery, AICD, or heart transplantation was evaluated on Mortality and recurrence of ventricular tachycardia. In patients with life-threatening ventricular tachycardia, electrophysiologically guided surgery yielded a 5% recurrence rate in ischemic cases, while AICD provided 83% 1-year survival.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: